Japan Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

Japan’s infection control market is evaluated at US$1,403.32 million for the year 2020 and is projected to grow at a CAGR of 11.39% to reach a market size of US$2,985.01 million by the year 2027. With Japan being the third-largest economy in the world, the country has a high standard of living, a high standard of safety, development, and stability. Hence, these factors contributed to significant achievements in the field of healthcare as well including full implementation of universal insurance coverage, attaining the world’s highest life expectancy, and control and eradication of common infectious diseases. In spite of all these achievements, the country is also facing certain challenges, which include a poor fertility rate resulting in negative population growth and housing the world’s maximum geriatric population. Hence, with the prevalence of elderly people, age-associated diseases will also increase, further demanding better health facilities for healthy ageing. This provides a robust potential for the market to increase at a sustainable pace with a high market size in the forecast period and in the upcoming years.

The increasing demand for long-term care facilities with sufficient healthcare facilities is driving the market demand in the forecast period and in the upcoming years.

With the increasing demand for long-term care, keeping in view the status of the growing geriatric population as well in the country, the market is projected to fuel in the forecast period. The provision of long-term care has to be accommodated by sophisticated healthcare facilities and not by welfare facilities. The provision of nursing homes in the country was always in short supply as decisions for admissions to nursing homes were made by the welfare offices of the municipal governments. Additionally, the planned evolution to attain a sustainable healthcare system is focused on the shifting of the healthcare system from volume-based to value-based care, from cure to care, and from specialization to integrated approaches throughout all sectors. This will certainly augment the market demand in the future as well.

The presence of chronic diseases, especially among older adults in Japan, is propelling the market growth in the forecast period.

It was noticed that cancer, cerebrovascular accidents, and coronary heart disease are common causes of death in the country. These were, however, recorded among older adults. The presence of multimorbidity, which is defined as the presence of two or more two disorders in an individual, is further providing an opportunity for the market to grow in the forecast period. Management strategies for handling multi-morbidity cases may involve complicated treatment procedures with high risks of adverse drug events, however, this may not affect the growth of the infection control product sales. Many doctors focusing on the treatment of single diseases will further increase the market demand over the next five years. Furthermore, with the growing aging of the population in Japan, the chances of age-associated diseases will increase, hence, the market for infection control holds strong growth prospects with the surging demand for the adoption of healthy ageing practices which require early disease detection and regular hospital or clinic visits in order to keep track of the health of the individual’s right from a younger age.

COVID-19 SCENARIO

The coronavirus infection spread quickly and was aided in part by the market for controlling acquired diseases because there were few protective measures in place. The majority of the cases of COVID-19 among medical personnel were brought on by contact and infection transmission within hospital settings. Hospital-acquired infections received a lot more attention after the pandemic's seriousness was apparent, and numerous controls were put in place to reduce them. As a result, hospital-acquired infection control equipment was in extremely high demand. As the pandemic ends, it is anticipated that demand for hospital-acquired infection control devices would decline. However, rising awareness of hospital-acquired infections is anticipated to keep the industry afloat at a modest rate during the ensuing years.

Key Developments

• April 2020- As the government cracks down on coronavirus profiteering, Japanese cosmetics manufacturers and distillers scramble to produce sanitizers. Shiseido and Suntory expand their production.

Japan Infection Control Market Scope:

Market Segmentation:

• By Product
  • Disinfectant
  • Sterilization
    • Low temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical